STAT+: Pharmalittle: We’re reading about biotech investors’ mood, a former FDA head’s confidence, and more

Biotech investors' concerns about the Make America Healthy Again movement are fading, and a former FDA head has confidence in the agency's new acting commissioner. The FDA has faced recent tumult, but an inflection point may be nearing. The mood among biotech investors is improving due to decreased political risk.